Europe Cell Signaling Market Size & Outlook, 2023-2030
The cell signaling market in Europe is expected to reach a projected revenue of US$ 2,933.3 million by 2030. A compound annual growth rate of 7.4% is expected of Europe cell signaling market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,784.2
Forecast, 2030 (US$M)
$2,933.3
CAGR, 2024 - 2030
7.4%
Report Coverage
Europe
Europe cell signaling market, 2018-2030 (US$M)
Related Markets
Europe cell signaling market highlights
- The Europe cell signaling market generated a revenue of USD 1,784.2 million in 2023.
- The market is expected to grow at a CAGR of 7.4% from 2024 to 2030.
- In terms of segment, endocrine signaling was the largest revenue generating type in 2023.
- Endocrine Signaling is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 1,784.2 million |
| Market revenue in 2030 | USD 2,933.3 million |
| Growth rate | 7.4% (CAGR from 2023 to 2030) |
| Largest segment | Endocrine signaling |
| Fastest growing segment | Endocrine Signaling |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Endocrine Signaling, Paracrine Signaling, Autocrine Signaling |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Becton Dickinson & Co, Bio-Rad Laboratories Inc, Bio-Techne Corp, Cell Signaling Technology, Danaher Corp, Merck KGaA, PerkinElmer, Promega |
Other key industry trends
- In terms of revenue, Europe region accounted for 33.0% of the global cell signaling market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,381.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Signaling Market Scope
Cell signaling market segmentation & scope
Cell Signaling Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe cell signaling market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell signaling market will help companies and investors design strategic landscapes.
Endocrine signaling was the largest segment with a revenue share of 42.91% in 2023. Horizon Databook has segmented the Europe cell signaling market based on endocrine signaling, paracrine signaling, autocrine signaling covering the revenue growth of each sub-segment from 2018 to 2030.
- Europe Cell Signaling Type Outlook (Revenue, USD Million, 2018-2030)
- Endocrine Signaling
- Paracrine Signaling
- Autocrine Signaling
- Others
- Europe Cell Signaling Product Outlook (Revenue, USD Million, 2018-2030)
- Consumables
- Instruments
- Europe Cell Signaling Technology Outlook (Revenue, USD Million, 2018-2030)
- Flow Cytometry
- Microscopy
- Western Blotting
- ELISA
- Other Technologies
- Europe Cell Signaling Pathway Outlook (Revenue, USD Million, 2018-2030)
- AKT Signaling Pathway
- AMPK Signaling Pathway
- ErbB/HER Signaling Pathway
- Other Signaling Pathways
Reasons to subscribe to Europe cell signaling market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe cell signaling market databook
-
Our clientele includes a mix of cell signaling market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe cell signaling market, including forecasts for subscribers. This continent databook contains high-level insights into Europe cell signaling market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe cell signaling market report size, by country, 2018-2030 (US$M)
Europe Cell Signaling Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
